Effect of oral cavity treatment and Gastric Helicobacter pylori eradication : a prospective randomized control clinical trial
Not Applicable
Completed
- Conditions
- only patient with oral and gastric Helicobacter pylori infection included in this studyOral diseaseHelicobacter pylori eradication
- Registration Number
- TCTR20170324001
- Lead Sponsor
- Suranaree University of Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 700
Inclusion Criteria
patients with gastrointestinal complaints, who had been diagnosed with the H. pylori infection both stomach and oral cavity using the standard method of PCR, regardless of the duration or severity of their illnesses, or whether those illnesses may have been combined with other diseases.
Exclusion Criteria
patients who had taken antibiotics and/or proton pump inhibitors within four weeks prior to sample collection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method gastric H.pylori eradiaction Eradication rate,Helicobacter eradication rate of both group 10 month PCR,stool antigen ,
- Secondary Outcome Measures
Name Time Method Virulence factor of the Helicobacter pylori in the stomach and oral carvity 10 month PCR,Prevalence of Helicobacter pylori infection in the gastric mucosa and oral cavity 10 month PCR